The Hotgen™ COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged two years or older, with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged two years or older with or without symptoms or other epidemiological reasons to suspect COVID-19 infection, 5.when tested twice over three days with at least 48 hours between tests.
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus.
Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age.
The best way to prevent and slow down transmission is to be well informed about the disease and how the virus spreads.
Private and Reliable
At-home Covid-19 testing is that tests are private and discreet, soothing the nerves of concerned family.
Fast answers before and after work
As safe as it is convenient, results can be quickly obtained without having to disrupt your schedule, avoiding unnecessary exposure.
Improved experiences for students protection
Identifying infections early, testing helps keep COVID-19 transmission low and students in school for in-person learning and normal activities.
Beijing Hotgen Biotech Co., Ltd. (Hotgen Biotech, stock code: 688068) was founded in June 2005 as a high-tech enterprise focusing on the research & development, and manufacture of in-vitro diagnostics (IVD) medical equipment and antibody biomedicine.
After years of research, Hotgen Biotech has developed 8 major technology platforms,such as In Vitro diagnostic reagent bioactive raw material development platform, glycoprotein capture technical platform, magnetic particles chemiluminescence, up-converting phosphor, and colloidal gold-based immunoassay. These technology platforms form a closed-loop system for in-vitro diagnostic R&D and production.